Form 8-K

0001193125-21-200603.txt : 20210625 0001193125-21-200603.hdr.sgml : 20210625 20210625172122 ACCESSION NUMBER: 0001193125-21-200603 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20210624 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20210625 DATE AS OF CHANGE: 20210625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39329 FILM NUMBER: 211049023 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 8-K 1 d196352d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

June 24, 2021

Royalty Pharma plc

(Exact Name of Registrant as Specified in its Charter)

England and Wales

001-39329

98-1535773

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

110 East 59^th Street

New York, New York

10022

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code: (212) 883-0200

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of each class

Trading

symbol(s)

Name of each exchange

on which registered

Class A Ordinary Shares, par value $0.0001 per share

RPRX

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 24, 2021, Royalty Pharma plc (the “Company”) held its annual general meeting of shareholders (the “Annual Meeting”). At the Annual Meeting, the Company’s shareholders voted on nine proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 29, 2021 (the “Proxy Statement”). There were 520,357,278 shares of the Company’s Class A ordinary shares and Class B ordinary shares, voting as a single class, present or represented by proxy at the Annual Meeting, which represented 85.71% of the combined voting power of the Class A ordinary shares and Class B ordinary shares entitled to vote at the Annual Meeting, and which constituted a quorum for the transaction of business. Holders of the Company’s Class A ordinary shares and Class B ordinary shares were entitled to one vote for each share held as of the record date described in the Proxy Statement. The Company’s inspector of election certified the following vote tabulations:

Proposal 1. To elect ten directors, each by separate ordinary resolutions, to the Company’s Board of Directors to serve until the 2022 Annual General Meeting of Shareholders:


Nominee	For	Against	Abstain	Broker Non-Votes
Pablo Legorreta	502,073,466	1,399,424	1,597,176	15,287,212
Henry Fernandez	503,560,739	816,295	693,032	15,287,212
Bonnie Bassler	503,466,513	982,234	621,319	15,287,212
Errol De Souza	482,493,429	21,955,033	621,604	15,287,212
Catherine Engelbert	484,184,525	20,263,687	621,854	15,287,212
William Ford	502,626,681	1,822,021	621,364	15,287,212
M. Germano Giuliani	504,249,339	198,877	621,850	15,287,212
Ted Love	461,279,101	43,169,101	621,864	15,287,212
Gregory Norden	481,026,656	23,421,786	621,624	15,287,212
Rory Riggs	504,035,909	412,402	621,755	15,287,212

Proposal 2. To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers:

For

Against

Abstain

Broker Non-Votes

455,808,359

47,703,018

1,558,689

15,287,212

Proposal 3. To approve, on a non-binding advisory basis, the frequency of future non-binding advisory votes on the compensation of the Company’s named executive officers:

1 Year

2 Years

3 Years

Abstain

Broker Non-Votes

489,841,688

13,734,188

850,625

643,565

15,287,212

Proposal 4. To ratify the appointment of Ernst & Young Chartered Accountants (“Ernst & Young”) as the Company’s independent registered public accounting firm:

For

Against

Abstain

518,304,499

2,041,891

10,888

There were no broker non-votes on this proposal.

Proposal 5. To approve receipt of the Company’s U.K. statutory accounts together with the Company’s U.K. statutory reports, including the directors’ report, the strategic report, the directors’ remuneration report and the auditors’ report for the fiscal year ended December 31, 2020 (“U.K. Annual Report and Accounts”):

For

Against

Abstain

Broker Non-Votes

504,913,421

32,061

124,584

15,287,212

Proposal 6. To approve the Company’s U.K. directors’ remuneration policy, included in the directors’ remuneration report contained in the U.K. Annual Report and Accounts (the “U.K. Directors’ Remuneration Policy”):

For

Against

Abstain

Broker Non-Votes

504,059,318

188,282

822,466

15,287,212

Proposal 7. To approve, on a non-binding advisory basis, the Company’s U.K. directors’ remuneration report (excluding the U.K. Directors’ Remuneration Policy) in the U.K. Annual Report and Accounts:

For

Against

Abstain

Broker Non-Votes

456,981,235

47,267,001

821,830

15,287,212

Proposal 8. To re-appoint Ernst & Young as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the U.K. annual report and accounts are presented to shareholders:

For

Against

Abstain

518,378,063

1,948,264

30,951

There were no broker non-votes on this proposal.

Proposal 9. To authorize the board of directors to determine the remuneration of the Company’s U.K. statutory auditor:

For

Against

Abstain

Broker Non-Votes

503,470,716

1,576,890

22,460

15,287,212

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 25, 2021


ROYALTY PHARMA PLC

By:		/s/ George Lloyd
		George Lloyd
		Executive Vice President, Investments & General Counsel

EX-101.SCH 2 rprx-20210624.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 rprx-20210624_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Address, State or Province Entity Address, State or Province Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 rprx-20210624_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 d196352d8k_htm.xml IDEA: XBRL DOCUMENT 0001802768 2021-06-24 2021-06-24 NY false 0001802768 8-K 2021-06-24 Royalty Pharma plc X0 001-39329 98-1535773 110 East 59th Street NY New York 10022 (212) 883-0200 false false false false Class A Ordinary Shares, par value $0.0001 per share RPRX NASDAQ false XML 6 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	Jun. 24, 2021
Cover [Abstract]
Entity Address, State or Province	NY
Amendment Flag	false
Entity Central Index Key	0001802768
Document Type	8-K
Document Period End Date	Jun. 24, 2021
Entity Registrant Name	Royalty Pharma plc
Entity Incorporation State Country Code	X0
Entity File Number	001-39329
Entity Tax Identification Number	98-1535773
Entity Address, Address Line One	110 East 59th Street
Entity Address, City or Town	New York
Entity Address, Postal Zip Code	10022
City Area Code	(212)
Local Phone Number	883-0200
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Security 12b Title	Class A Ordinary Shares, par value $0.0001 per share
Trading Symbol	RPRX
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d196352d8k.htm rprx-20210624.xsd rprx-20210624_lab.xml rprx-20210624_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d196352d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d196352d8k.htm" ] }, "labelLink": { "local": [ "rprx-20210624_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "rprx-20210624_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "rprx-20210624.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "rprx", "nsuri": "http://imetrix.edgar-online.com/20210624", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d196352d8k.htm", "contextRef": "duration_2021-06-24_to_2021-06-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d196352d8k.htm", "contextRef": "duration_2021-06-24_to_2021-06-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imetrix.edgar-online.com//20210624/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001193125-21-200603-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-200603-xbrl.zip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end